Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koch

Showing results (451-460 of 726) with videos related to

Pageof 73
Sort By:
Genes|October 28, 2023
Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersDenise van der Drift, Mirjam Simoons, Birgit C P Koch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 5, 2023
Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography - tandem mass spectrometry: Method development and validationSoma Bahmany, Moska Hassanzai, Robert B Flint, et al.
International Journal of Antimicrobial Agents|July 23, 2023
Which patients benefit from model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin at the ICU?Tim M J Ewoldt, Alan Abdulla, Wim J R Rietdijk, et al.
Archives of Otolaryngology--Head & Neck Surgery|September 11, 2002
Inner ear anomalies are frequent but nonobligatory features of the branchio-oto-renal syndromeMartijn H Kemperman, Sacha M P Koch, Frank B M Joosten, et al.
Cancer|September 1, 1990
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study GroupW Hiddemann, N Schmitz, M Pfreundschuh, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
Cancer Research|December 18, 2015
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell PopulationNeil E Bhola, Valerie M Jansen, James P Koch, et al.
BMC Pregnancy and Childbirth|May 1, 2021
Objective assessment of alcohol consumption in early pregnancy using phosphatidylethanol: a cross-sectional studyLeonieke J Breunis, Sophie Wassenaar, Barbara J Sibbles, et al.
International Journal of Audiology|February 25, 2005
Evidence of progression and fluctuation of hearing impairment in branchio-oto-renal syndromeMathyus H Kemperman, Sacha M P Koch, Shrawan Kumar, et al.
Archives of Biochemistry and Biophysics|September 1, 1996
Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomesC J Patten, T J Smith, S E Murphy, et al.
Pageof 73

Showing results (451-460 of 726) with videos related to

Sort By:
Pageof 73
Genes|October 28, 2023
Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersDenise van der Drift, Mirjam Simoons, Birgit C P Koch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 5, 2023
Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography - tandem mass spectrometry: Method development and validationSoma Bahmany, Moska Hassanzai, Robert B Flint, et al.
International Journal of Antimicrobial Agents|July 23, 2023
Which patients benefit from model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin at the ICU?Tim M J Ewoldt, Alan Abdulla, Wim J R Rietdijk, et al.
Archives of Otolaryngology--Head & Neck Surgery|September 11, 2002
Inner ear anomalies are frequent but nonobligatory features of the branchio-oto-renal syndromeMartijn H Kemperman, Sacha M P Koch, Frank B M Joosten, et al.
Cancer|September 1, 1990
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study GroupW Hiddemann, N Schmitz, M Pfreundschuh, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
Cancer Research|December 18, 2015
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell PopulationNeil E Bhola, Valerie M Jansen, James P Koch, et al.
BMC Pregnancy and Childbirth|May 1, 2021
Objective assessment of alcohol consumption in early pregnancy using phosphatidylethanol: a cross-sectional studyLeonieke J Breunis, Sophie Wassenaar, Barbara J Sibbles, et al.
International Journal of Audiology|February 25, 2005
Evidence of progression and fluctuation of hearing impairment in branchio-oto-renal syndromeMathyus H Kemperman, Sacha M P Koch, Shrawan Kumar, et al.
Archives of Biochemistry and Biophysics|September 1, 1996
Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomesC J Patten, T J Smith, S E Murphy, et al.
Pageof 73